headerv2.gif

THE LATEST DEVELOPMENTS IN PRENATAL SCREENING


NEW ERA IN PREDICTION & PREVENTION OF PRE-ECLAMPSIA

The results from the ASPRE study - the biggest prospective, randomized placebo controlled trial ever undertaken on the prophylactic use of aspirin in women at increased risk of pre-eclampsia recruited more than 33,000 pregnancies in six European countries including the UK.  

PerkinElmer’s high-sensitivity PlGF 1-2-3™ assay kit is the only assay used to deliver the outcomes achieved in the ground-breaking ASPRE trial.


Join us and experts in the field:

Learn more about the new optimized screening protocol and be part of the new era in improved pre-eclampsia management as well as the up and coming Vanadis NIPT solution for trisomy screening.

AgendaV2.jpg

REGISTER TODAY

Sydney Seminar - 10th Oct
Melbourne Seminar - 11th Oct
Name *
Name